Obesity: Lorcaserin-not a new weapon in the battle with appetite

Nature Reviews Endocrinology

Volumn 6, Issue 12, 2010, Pages 663-664

  Halford, Jason C G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ANTIOBESITY AGENT; LORCASERIN; PLACEBO; SIBUTRAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 1 METHYL 1H 3 BENZAZEPINE; 8-CHLORO-2,3,4,5-TETRAHYDRO-1-METHYL-1H-3-BENZAZEPINE; BENZAZEPINE DERIVATIVE; SEROTONIN AGONIST;

BEHAVIOR THERAPY; CLINICAL TRIAL; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; OBESITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; WEIGHT REDUCTION; ADULT; APPETITE; ARTICLE; EVALUATION; FOOD INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; TREATMENT OUTCOME;

ADULT; ANTI-OBESITY AGENTS; APPETITE; APPETITE DEPRESSANTS; APPETITE REGULATION; BENZAZEPINES; HUMANS; OBESITY; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK REDUCTION BEHAVIOR; SEROTONIN RECEPTOR AGONISTS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 78649428304     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.193     Document Type: Short Survey

References (9)

1. Smith, S. R. et al. Multicenter, placebo-controlled trial of Lorcaserin for weight management. N. Engl. J. Med. 363, 245-256 (2010).
2. Warren, C. & Cooper, P. J. Psychological effects of dieting. Br. J. Clin. Psychol. 27, 269-270 (1988).
3. Blundell, J. E. et al. Overconsumption and obesity: peptides and susceptibility to weight gain. Regul. Pept. 149, 32-38 (2008).
4. Blundell, J. E. & Finlayson, G. Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? Physiol. Behav. 82, 21-25 (2004).
5. Halford, J. C. G., Boyland, E. J., Blundell, J. E., Kirkham, T. C. & Harrold, J. A. Pharmacological management of appetite expression in obesity. Nat. Rev. Endocrinol. 6, 225-269 (2010).
6. Elfhag, K., Finer, N. & Rössner, S. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes. Metab. 10, 498-505 (2008).
7. Halford, J. C., Harrold, J. A., Boyland, E. J., Lawton, C. L. & Blundell, J. E. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 67, 27-55 (2007).
8. Li, Z. et al. Meta-analysis: pharmacologic treatments of obesity. Ann. Intern. Med. 142, 532-546 (2005).
9. Elfhag, K. & Rössner, S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes. Rev. 6, 67-85 (2005).